Stocksigma LogoStocksigma Logo

Panacea Biotec Discloses FY25-26 Business Responsibility and Sustainability Report

Panacea Biotec submitted its standalone BRSR for FY25-26 on 7th Sep'26. The company reported standalone turnover of ₹4,134.92m, with pharmaceuticals

Panacea Biotec Discloses FY25-26 Business Responsibility and Sustainability Report

Panacea Biotec Ltd · Others (Uncategorized) · 08 Sept 2026, 12:17 am

Panacea Biotec Discloses FY25-26 Business Responsibility and Sustainability Report Panacea Biotec submitted its standalone BRSR for FY25-26 on 7th Sep'26. The company reported standalone turnover of ₹4,134.92m, with pharmaceuticals contributing 100% and exports accounting for ~65% across ~37 countries. Net worth stood negative at ₹(487.92)m. Operational metrics showed energy intensity improving slightly to 53.25 GJ/₹m turnover (vs 53.55 YoY) and water intensity dropping to 45.34 kl/₹m turnover (vs 56.06 YoY). Total Scope 1 and Scope 2 GHG emissions reached 23,627.64 tCO₂e. Additionally, accounts payable days shortened significantly to 158 days from 230 days in FY24-25.

Original exchange filing (PDF)

More announcements from Panacea Biotec Ltd

All Panacea Biotec Ltd announcements